To determine whether the adventitia that surrounds pulmonary vessels acts as a barrier specific to nitric oxide, special lucite chambers were constructed to measure the force of contraction of rabbit pulmonary artery rings in which the endothelial or adventitial surfaces could be preferentially exposed to nitric oxide (NO), carbon monoxide (CO), or sodium nitroprusside (SNP). Delivery of NO to the endothelial and adventitial surfaces of preconstricted vessels produced markedly different concentration-response curves with maximal relaxations of 89±3 and 11±9%, respectively. In contrast, relaxations induced by both CO and SNP did not differ significantly between endothelial and adventitial exposure to these agents. Placement of a layer of pericardium onto the endothelial surface eliminated relaxation to the endothelial delivery of NO but not to CO. We conclude that the pulmonary vascular response to NO displays a striking sidedness which is not observed either with CO, another gas of similar molecular weight, or with SNP, both of which cause relaxation by stimulating guanylate cyclase. The elimination of NO but not CO relaxations with a layer of pericardium may indicate that the adventitia acts as a barrier specific to NO. This directionality of effect provides evidence for a highly localized regulation of pulmonary vascular tone by endothelial cell NO and also indicates that extravascular NO may have limited access to pulmonary vascular smooth muscle. (J.
Introduction
The mechanism by which nitric oxide (NO) regulates vascular tone has been studied extensively over the past decade ( 1-3 ). It is now clear that NO can be produced by several forms of NO synthase that are present in many different cell types (4, 5) . Thus, in addition to endothelial cells, NO may be produced by macrophages (6) , mast cells (7), neutrophils (8) , and even vascular smooth muscle cells (9) . Moreover, intracellular regulatory mechanisms for NO, and the amounts of NO produced, vary widely among cell types, depending on constitutive versus inducible forms of NO synthase as well as whether the NO produced is destined for the regulation of vascular smooth muscle tone, platelet aggregation, or cytotoxic effects (4, 5) .
Pulmonary vascular tone is regulated by the smooth muscle layer that encircles both pulmonary arteries and veins. This layer of smooth muscle is in the unique position of potentially being influenced by NO produced by both endothelial cells and extravascular sources such as activated macrophages, mast cells, or neutrophils that are recruited into the lung during periods of inflammation. If the NO produced by these extravascular sources gains ready access to the pulmonary vascular smooth muscle across the adventitia, then it might interfere with normal regulation of vascular tone by endothelial cells and produce a general state of pulmonary vasodilation.
Exogenous NO gas delivered via the airspaces is a selective pulmonary vasodilator in awake lambs (10) (11) (12) . These findings have led to the development of clinical studies using inhaled NO to treat various forms of pulmonary hypertension. It has been presumed, but not determined, that this inhaled NO gains access to the pulmonary vascular smooth muscle by traversing the adventitia (10) .
The purpose of this study was to investigate whether the adventitial layer that surrounds pulmonary vessels might act as a barrier to prevent extravascular sources of NO from influencing pulmonary vascular tone. To test this hypothesis, a new tissue holder was developed. This device has the advantage of directly measuring the force of contraction of isolated rabbit pulmonary arteries while the endothelial and adventitial surfaces are superperfused separately. Exogenous NO Protocols involving the use of sodium nitroprusside (SNP)' were performed in a darkened room in order to prevent the photochemical release of NO (13) . Drugs used in this study included acetylcholine chloride, phenylephrine hydrochloride, SNP, and SOD. All drugs were purchased from Sigma Chemical Co. (St. Louis, MO). All drugs were dissolved in deionized water just before experimentation. Drugs were added to the 6-ml perfusion solution in aliquots of < 50 01 and were removed by repeated washing over a 45-min period when applicable. NO gas was obtained from Matheson Gas Products (Twinsburg, OH) and CO gas was obtained from Linde (Danbury, CT).
In all experiments, n represents the number of animals from which vessel rings were studied. Data are expressed as means±SEM. Statistical comparison was performed on concentration-response curves using ANOVA with Student-Newman-Keuls test for post hoc testing of multiple comparisons, when appropriate. Individual data points between curves were compared using Students' unpaired t test. Significance was accepted at P < 0.05.
Results
A typical protocol is shown in Fig. 2 . This pulmonary artery segment was mounted endothelial surface down and it contracted vigorously in response to an ED50 of phenylephrine delivered to both the endothelial and adventitial surfaces simultaneously. Once the contraction reached a plateau, NO was injected into the reservoir supplying the endothelial (lower) surface in increasing concentrations as shown. NO produced a marked concentration-dependent relaxation of this pulmonary artery.
To demonstrate that chamber design did not influence the results, eight vessel segments were studied, using each vessel as its own control. One group of four vessels was mounted endothelial surface up, and the second group of four was mounted endothelial surface down. In half of the vessels in each group, NO was delivered first to the upper chamber and then to the lower chamber after a wash in between and subsequent readdition of phenylephrine. The other two vessels in each group received the reverse order of NO delivery. Mean was 1 . Abbreviations used in this paper: EDRF, endothelium-derived relaxing factor; SNP, sodium nitroprusside. for each curve. PL, plateau contraction (100%) to 1 tiM phenylephrine (Plateau contraction force: group A = 698±92 g for endothelial NO and 676±102 g for adventitial NO. Group B = 669±98 g for endothelial NO and 725±109 g for adventitial NO.) calculated with all data taken together and the results are shown in Fig. 3 . Regardless of which vessel orientation was examined, the endothelial delivery of NO always produced a substantially greater degree of relaxation than the adventitial delivery of NO. However, the endothelial delivery of NO produced the least relaxation when the vessels were mounted endothelial surface up, because the solution in the upper chamber was exposed to air, allowing some NO to escape. For this reason, all subsequent protocols were performed with delivery of NO, CO, or SNP to the lower chamber only.
A comparison of endothelial versus adventitial exposure to NO is shown in Fig. 4 for both endothelial and adventitial exposure). In three of the six vessels exposed to adventitial NO, the highest concentration of NO (965 ppm) was delivered two more times at 1-min intervals after the initial exposure to 965 ppm NO. The level of relaxation was not enhanced after these repetitive exposures to 965 ppm NO. However, adventitial exposure to 10% NO (100,000 ppm) relaxed vessels by 86% (Fig. 4 , n = 2). The difference between endothelial and adventitial delivery of NO persisted in endothelium-denuded vessels (Fig. 5) , although the relaxation response to adventitial NO was somewhat greater than in endothelium-intact vessels (Fig. 4) at NO concentrations > 10 ppm. A layer of pericardium was dissected from around the rabbit heart and placed in contact with the endothelial surface in another group of pulmonary arteries. This layer of pericardium significantly reduced the level of relaxation to endothelial delivery of NO when compared with control (Fig. 6) . Indeed, this NO concentration-response curve in the presence of the pericardium does not differ significantly from the adventitial delivery of NO (Fig. 4) at any concentration of NO. In this protocol, the pericardium was removed after the initial NO concentration-response curve was obtained and the tissue was remounted endothelial surface down. Removal of the pericardium restored responses to the endothelial delivery of NO (data not shown).
CO also relaxed pulmonary arteries contracted by an ED50 of phenylephrine, although to a lesser degree than NO (Fig. 7) . In marked contrast to the results obtained with NO, endothelial versus adventitial CO concentration-response curves were not significantly different (P > 0.05) at any CO concentration. Moreover, addition of a layer of pericardium to the endothelial surface had no effect on relaxations to CO.
There was no significant difference between the relaxations elicited by SNP delivered to either the endothelial or adventitial surfaces of rabbit pulmonary arteries (Fig. 8) .
The Adventitia May Be a Barrier Specific to NO 1885 10- The striking sidedness of the response to NO suggests that either the endothelial cell layer or the adventitia might regulate access of exogenous NO gas to the underlying layer of smooth muscle. Removal of the endothelium did not alter the differential response to NO, indicating that this cell layer is not involved. Attempts to remove the adventitia either by mechanical dissection or enzymatic digestion were not successful because small holes eventually developed in the remaining tissue. This likely disrupted contractile mechanisms and allowed NO to pass from one side of the tissue to the other.
An alternative to removal of the adventitia was to place an adventitia-like layer of elastin and collagen over the endothelial surface and test its ability to prevent access of NO to the smooth muscle layer. In this study, a layer of pericardium significantly reduced the level of relaxation to the endothelial delivery of NO. The pericardium was effective whether the endothelium was intact or denuded (data not shown) and removal of the pericardium restored responses to the endothelial delivery of NO. Thus, the adventitia may prevent exogenous NO gas from gaining access to the underlying layer of smooth muscle. This hypothesis receives support from the current study, as the effect of NO delivered to the adventitial surface was slightly greater in endothelium-denuded than in intact vessels. It is likely that the mechanical process used to remove the endothelium also produces some abrasion of the adventitia and compromises its ability to restrict NO access to the smooth muscle layer.
Two other studies using superfusion bioassay techniques with donor and recipient vessels have investigated the ability of endothelium-derived relaxing factor (EDRF) generated in response to acetylcholine to cross from the inside to the outside of the vessel wall. Vedernikov et al. ( 14) reported no transition for EDRF through the vessel wall of rabbit thoracic aorta and femoral artery, and concluded that local metabolic factors located in the adventitia can influence endothelial cell function.
Bassenge et al. (15) reported similar findings in the same species and vessels and, in addition, found that EDRF from cultured bovine endothelial cells elicited smaller dilation (9±4%) when applied to the adventitial side of endothelium-denuded vessels, compared with endothelial application (92+7%). However, they reasoned that the adventitia was not a barrier because subsequent histological examination revealed that the adventitia was not a continuous layer in any vessel studied. A damaged adventitia probably resulted from trauma associated with the techniques used to remove the endothelium, as well as the eversion and inversion techniques they used to study their vessels. Instead, they attributed differences in endothelial versus adventitial exposure to EDRF to an outer layer of smooth muscle that was less sensitive to EDRF than the inner layer.
The differences between our study and those of Vedernikov et al. (14) and Bassenge et al. (15) are numerous. First, they studied major systemic blood vessels, while we studied smaller pulmonary blood vessels. In addition, they studied responses to EDRF generated by acetylcholine rather than exogenous NO gas and they did not use SOD in their superfusion systems. Thus, problems associated with small amounts of endogenously produced NO, the short half-life of NO due to rapid metabolism by superoxide anion, and dilution factors inherent to cascadetype superfusion systems were less of a concern with our unique tissue holder. Also, we used extreme care to avoid any damage to the adventitial surface and we also were able to demonstrate that an adventitial-like layer of pericardium placed over the endothelial surface could mimic the response to the adventitial delivery of NO.
In addition, we studied relaxations to SNP and CO to determine whether the differential response to NO was unique to this molecule. These agents were chosen because, like NO, they induce relaxation of vascular smooth muscle by stimulating guanylate cyclase. SNP is a potent vasodilator that causes smooth muscle relaxation by releasing NO, which then activates guanylate cyclase (13, 16) . Relaxations induced by SNP did not differ significantly between adventitial and endothelial exposure to this agent. Release of NO from SNP requires the presence of reducing agents in biological tissues and does not occur in the dark in the absence of tissue (13) . Thus, SNPinduced relaxations in the current study most likely occurred after SNP diffused across the adventitia and released NO either within or in close proximity to the smooth muscle cells. The similarity of relaxations between endothelial and adventitial delivery of SNP indicate that the adventitia does not act as a diffusion barrier to this agent, and that NO is released after the SNP has crossed the adventitia. CO, an agent with very similar physical properties to NO, did not relax vessels differently depending upon the side from which it was administered. CO binds to the heme moiety of guanylate cyclase (1) and activates this enzyme for the production of cyclic GMP (17) . CO reportedly causes relaxation of porcine coronary arteries (18) and inhibition of platelet aggregation (19) by activating guanylate cyclase. In marked contrast to NO, we observed that relaxations induced by CO were similar between endothelial and adventitial exposures to this agent. Moreover, placement of a layer of pericardium over the endothelial surface did not alter CO-induced relaxations. NO and CO have mol wt of 30.01 and 28.01, respectively; solubilities in water of 4.6/100 ml and 2.3/100 ml at 20°C, respectively; and solubilities in ethanol of 26.6/100 ml and 19.0/100 ml at 200C, respectively (20) . It is unlikely that these small differences in physical properties explain the presence of differential responses to NO as well as their absence to CO. Quantitatively, CO-induced relaxations were significantly smaller in magnitude than NO-induced relaxations (endothelial delivery, Figs. 4 and 7) . The lower solubility of CO in both water and ethanol compared with NO may be partly responsible for this observation. In addition, the overall stability of NO-guanylate cyclase may be greater than CO-guanylate cyclase. At least for hemoglobin, NO binds to the heme moiety of this molecule two orders of magnitude faster than CO, and dissociates from hemoglobin 20 times more slowly than CO (4) .
Other vasoactive agents also display differences between endothelial and adventitial potencies. For example, Lew et al. (21) reported that small arterioles in hamster cheek pouch are 100 times more sensitive to phenylephrine when applied to the adventitial surface than when applied to the endothelial surface. The adventitial potency was highly correlated with the octanol/ water partition coefficient of phenylephrine and several vasoactive agents. They concluded that the endothelium forms a barrier to the diffusion of small water soluble molecules from the lumen to the smooth muscle layer. Because the ethanol/ water partition coefficients of NO (6.0) and CO (8.3) are quite similar, it does not appear that this factor alone can account for the differences in adventitial versus endothelial potencies of NO and CO in the current study.
The above results indicate that the adventitia acts as a barrier specific to NO. The major difference between NO and CO is that NO is a highly reactive free radical. We hypothesize that NO reacts with and is inactivated by some component of the adventitia, thereby reducing its effective concentration, whereas CO and SNP freely pass through this layer. Potential inactivating mechanisms might include superoxide-or transition metalcontaining proteins. Although SOD was used in all experiments, the concentration might not have been sufficient to counteract adventitial superoxide production. Since the adventitia is much thicker than the single-cell endothelial layer, its barrier effect may be primarily due to its increased path length. However, reports that the single-cell airway epithelial layer also acts as a barrier to NO relaxations of tracheal smooth muscle indicate that this effect may be much more specific than simple path length (22 
